CL097

CL097 Struktur
1026249-18-2
CAS-Nr.
1026249-18-2
Englisch Name:
CL097
Synonyma:
CL097;3H-Imidazo[4,5-c]quinolin-4-amine, 2-(ethoxymethyl)-;CL 097,Immunological,inhibit,Oligonucleotide,Toll-like Receptor (TLR),Peptide,TLR7,Heterocycle,modulators,Inhibitor,Reactive Oxygen Species,TLR8,CL-097
CBNumber:
CB13310325
Summenformel:
C13H14N4O
Molgewicht:
242.28
MOL-Datei:
1026249-18-2.mol

CL097 Eigenschaften

storage temp. 
Store at -20°C
Löslichkeit
DMSO : 100 mg/mL (412.75 mM; Need ultrasonic)
Aggregatzustand
Solid
Farbe
White to off-white

Sicherheit

CL097 Chemische Eigenschaften,Einsatz,Produktion Methoden

CL097 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


CL097 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 19)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 32063 58
TargetMol Chemicals Inc.

support@targetmol.com United States 38463 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 52925 58
Hangzhou ChangCun Biotechnology Co., Ltd. 0571-; 13567100326
158848739@qq.com China 108 50
Beijing Solarbio Science & Tecnology Co., Ltd. 010-50973130 4009686088
3193328036@qq.com China 29785 68
Nanjing crow LuNing pharmaceutical technology co., LTD 13382066392
CHINA 4877 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24648 58
Suzhou Zhixin Biotechnology Co., Ltd. 0512-65118909 15162312715
sales@szzxbio.com China 2991 58
Nantong QuanYi Biotechnology Co., Ltd 0513-66337626 18051384581
sales@chemhifuture.com China 4870 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
customer_service@efebio.com China 11974 58

  • CL097
  • 3H-Imidazo[4,5-c]quinolin-4-amine, 2-(ethoxymethyl)-
  • CL 097,Immunological,inhibit,Oligonucleotide,Toll-like Receptor (TLR),Peptide,TLR7,Heterocycle,modulators,Inhibitor,Reactive Oxygen Species,TLR8,CL-097
  • 1026249-18-2
Copyright 2019 © ChemicalBook. All rights reserved